Eurocine Vaccines initiates process development of the vaccine candidate against chlamydia

Today, Eurocine Vaccines AB (“Eurocine Vaccines”) announces the completion of knowledge transfer and preparations for the development of the manufacturing process to secure the active…

Eurocine Vaccines confirms good immunological effect in preclinical study with the chlamydia vaccine candidate

Eurocine Vaccines AB (“Eurocine Vaccines”) confirms good immunological effect in a preclinical animal study with its chlamydia vaccine candidate. The study confirms that an adapted…

Eurocine Vaccines publishes half-year report for July-December 2020

Eurocine Vaccines AB (“Eurocine Vaccines”) hereby publishes an interim report for the first half year of 2020. Below is a summary of the report. The…


Interim Report

Interim Report July 2020-March 2021 to be published.Read More